Moshirfar Majid, Durnford Kathryn, Megerdichian Alin, Thomson Andrew, Martheswaran Tanisha, West William, McCabe Shannon, Ronquillo Yasmyne, Hoopes Philip
Hoopes Vision, HDR Research Center, Ophthalmology University of Utah Health Sciences Center, 11820 S. State Street Suite #200, Draper, UT, 84020, USA.
Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, Salt Lake City, UT, USA.
Ophthalmol Ther. 2022 Apr;11(2):785-795. doi: 10.1007/s40123-022-00472-4. Epub 2022 Feb 15.
Treatment of mixed astigmatism with laser in situ keratomileusis (LASIK) is complex as the correction requires flattening the cornea in one meridian while steepening the cornea in the other meridian. The bitoric technique has become the most popular approach and has been tested across a variety of platforms. This study is the first to evaluate the results of mixed astigmatism treatment using the Allegretto WaveLight EX500.
This study was a single-center, retrospective, noncomparative analysis of 400 eyes that underwent LASIK to correct for mixed astigmatism utilizing the EX500 excimer laser. Data on uncorrected distance visual acuity, corrected distance visual acuity, and spherical equivalent was analyzed at consecutive intervals (1, 3, 6, 9, and 12 months). Refractive measurements were used to perform a vector analysis.
Three and 12 months postoperatively, 71% and 74% of eyes had an uncorrected distance visual acuity (UDVA) of 20/20 or better and 99% and 100% of eyes had a UDVA of 20/40 or better, respectively. The postoperative UDVA was within one line of the corrected distance visual acuity (CDVA) in 88% and 93% of eyes at 3 and 12 months, respectively. At 3 months, 78% of eyes achieved refractive astigmatism no greater than 0.50 diopters and at 12 months, 80% achieved this. The mean spherical equivalent refraction was - 0.36 ± 0.57 D at 12 months after surgery. At the 12-month follow-up, the mean refractive cylinder was reduced by 87%, from - 2.79 to - 0.37 diopters. On vector analysis, 99% of eyes had an angle of error within ± 15° from the intended target at 3 and 12 months.
Treatment of mixed astigmatism using the Allegretto WaveLight EX500 laser exceeded the industry standards of safety, efficacy, stability, and accuracy.
用准分子原位角膜磨镶术(LASIK)治疗混合性散光较为复杂,因为矫正需要在一个子午线方向使角膜变平,而在另一个子午线方向使角膜变陡。双曲面技术已成为最常用的方法,并已在多种平台上进行了测试。本研究首次评估了使用鹰视蓝调酷眼EX500治疗混合性散光的效果。
本研究是一项单中心、回顾性、非对比性分析,纳入了400只接受LASIK手术以矫正混合性散光的眼睛,使用EX500准分子激光。对未矫正远视力、矫正远视力和等效球镜度的数据在连续时间点(1、3、6、9和12个月)进行分析。屈光测量用于进行矢量分析。
术后3个月和12个月时,分别有71%和74%的眼睛未矫正远视力(UDVA)达到20/20或更好,99%和100%的眼睛UDVA达到20/40或更好。术后3个月和12个月时,分别有88%和93%的眼睛的术后UDVA在矫正远视力(CDVA)的一行以内。3个月时,78%的眼睛屈光性散光不超过0.50屈光度,12个月时,80%的眼睛达到此标准。术后12个月时等效球镜度平均为-0.36±0.57D。在12个月的随访中,平均屈光柱镜度从-2.79减少到-0.37屈光度,减少了87%。矢量分析显示,3个月和12个月时,99%的眼睛误差角度在距预期目标±15°以内。
使用鹰视蓝调酷眼EX500激光治疗混合性散光在安全性、有效性、稳定性和准确性方面超出了行业标准。